Quantcast

Latest FDA Stories

2014-08-16 23:03:20

With Over 150 AndroGel Lawsuits Pending In The U.S., A Class Action Testosterone Therapy Lawsuit Has Been Filed In Canada Contending AbbVie Failed To Disclose The Health Risks Associated With The Testosterone Treatment Drug AndroGel Reports Wright & Schulte LLC Columbus, OH (PRWEB) August 16, 2014 The product liability lawyers at Wright & Schulte LLC have recently learned that a AndroGel class action lawsuit has been filed in London, Ontario, Canada (Court File No. 3704CP/14)...

2014-08-15 23:06:27

On August 11, the US FDA advised consumers not to purchase or use Herbal Vigor Quick Fix as it contains an undeclared drug ingredient. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) August 15, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on Herbal Vigor Quick Fix. The FDA advised consumers on August...

2014-08-14 23:11:14

With 15 interactive exercises, this workshop, taught by internationally renowned medical device process validation expert Dan O’Leary, is designed to provide industry best practices to achieve sustainable process validation with regulatory bodies around the world. Attendees will learn the theories of process validation and documentation and how to put them into practice. Falls Church, VA (PRWEB) August 14, 2014 Innovative Process Validation Strategies for Medical Devices: Proving Your...

2014-08-14 23:11:10

On August 4, Oasis Brands Inc. announced the recall of Qesito Casero 12oz due to possible health risk. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) August 14, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on Qesito Casero. Oasis Brands Inc. announced on August 4, that Qesito Casero 12oz is recalled...

2014-08-14 23:01:16

The Firm is representing numerous individuals who allegedly suffered life-threatening cardiovascular injuries prior to the 2012 NaturaLyte and GranuFlo recall. New York, NY (PRWEB) August 14, 2014 A U.S. Food and Drug Administration (FDA) initiative that allows public access to product recall information reveals that actions similar to one that has since prompted thousands of GranuFlo lawsuits (http://www.thegranuflolawsuit.com/) have increased dramatically over the past few years,...

2014-08-14 23:00:54

Patients in the Forest Hills, NY and Queens, NY area have a new, no downtime, and more convenient way to treat gum disease. LANAP® (Laser Assisted New Attachment Procedure) also supports bone tissue regeneration, an important breakthrough in the treatment of periodontal disease. (PRWEB) August 15, 2014 Certified Queens periodontist Dr. Prabha Krishnan announces that the FDA approved Laser Assisted New Attachment Procedure (LANAP®) supports regeneration of bone tissue which is...

2014-08-14 20:22:56

RIVER EDGE, N.J., Aug. 14, 2014 /PRNewswire/ -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for the treatment of chronic renal failure patients, announced today financial results for the three and six months ended June 30, 2014. Recent Highlights -- First commercial use of the Nephros on-line mid-dilution hemodiafiltration...

2014-08-14 16:27:40

Signs Business Collaboration in South Korea with Wonik Corporation BRIDGEWATER, N.J., Aug. 14, 2014 /PRNewswire/ -- CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiorenal and infectious disease, today announced the U.S. Food and Drug Administration (FDA) has agreed with the design of our pivotal Phase III protocol for Neutrolin® in Hemodialysis patients, and the company...

2014-08-14 16:27:26

Committee Voted Based on Clinical Data from Eight Efficacy Trials RIDGEFIELD, Conn., Aug. 14, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) Pulmonary-Allergy Drugs Advisory Committee (PADAC) voted [10 yes, 3 no] that existing data supports approval of Boehringer Ingelheim's investigational tiotropium bromide inhalation spray for long-term, once-daily maintenance treatment of bronchospasm associated...

2014-08-14 16:27:01

New data will be reported to FDA at patient-focused drug development meeting on 9/26; insights will help future PFF programs and services CHICAGO, Aug. 14, 2014 /PRNewswire-USNewswire/ -- The Pulmonary Fibrosis Foundation (PFF) today announced that it has funded a survey designed to collect patient insights, which will help inform decision makers with a better understanding of pulmonary fibrosis (PF). The information collected will provide a better understanding of patients' and...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.